Literature DB >> 16132495

Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

Me Haykin1, M Gorman, J van Hoff, Rk Fulbright, Jm Baehring.   

Abstract

OBJECTIVES: A delayed stroke-like leukoencephalopathy has been observed in patients receiving methotrexate (MTX) for childhood leukemia. Diffusion-weighted MRI (DWI) may help to distinguish between ischemic stroke and chemotherapy-related leukoencephalopathy. Although conventional MRI correlates have been described for this stroke-like syndrome, DWI data are largely unavailable. Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered subacute neurotoxicity after intrathecal MTX.
DESIGN: We reviewed the medical records of four patients, who were seen by us between July 2000 and February 2004 for sudden onset of a central neurological syndrome within days of intrathecal MTX. Patients underwent standardized MRI within 48 h of symptom onset; MRI included DWI and apparent diffusion coefficient (ADC) maps.
RESULTS: DWI of all patients revealed well-demarcated hyperintense lesions within the subcortical white matter corresponding to areas of restricted proton diffusion on ADC maps. Lesions exceeded the confines of adjacent vascular territories. Complete resolution of symptoms within 1-4 days was accompanied by normalization of ADC abnormalities.
CONCLUSIONS: DWI findings in this cohort seem to reflect cytotoxic edema within cerebral white matter suggesting a reversible metabolic derangement, rather than ischemia, as the basis for this syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16132495     DOI: 10.1007/s11060-005-4569-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid.

Authors:  Wilfrid Jaksic; Dusan Veljkovic; Chris Pozza; Ian Lewis
Journal:  Acta Haematol       Date:  2004       Impact factor: 2.195

2.  Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer.

Authors:  C T Quinn; J C Griener; T Bottiglieri; K Hyland; A Farrow; B A Kamen
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

3.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

Authors:  D H Mahoney; J J Shuster; R Nitschke; S J Lauer; C P Steuber; N Winick; B Camitta
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

4.  Transient tetraparesis after intrathecal and high-dose systemic methotrexate.

Authors:  G Massenkeil; E Späth-Schwalbe; B Flath; S Gottschalk; R Lehmann; R Arnold
Journal:  Ann Hematol       Date:  1998-11       Impact factor: 3.673

Review 5.  A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities.

Authors:  C T Quinn; B A Kamen
Journal:  J Investig Med       Date:  1996-12       Impact factor: 2.895

Review 6.  Biochemical and clinical aspects of methotrexate neurotoxicity.

Authors:  Sandra Vezmar; Achim Becker; Udo Bode; Ulrich Jaehde
Journal:  Chemotherapy       Date:  2003-05       Impact factor: 2.544

7.  Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions.

Authors:  A L Tievsky; T Ptak; J Farkas
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

8.  Neurotoxicity of intrathecal methotrexate: MR imaging findings.

Authors:  Claudio Sandoval; Martin Kutscher; Somasundaram Jayabose; Michael Tenner
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

9.  Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity.

Authors:  Richard A Drachtman; Peter D Cole; Carla B Golden; S Jill James; Stepan Melnyk; Jospeh Aisner; Barton A Kamen
Journal:  Pediatr Hematol Oncol       Date:  2002 Jul-Aug       Impact factor: 1.969

10.  High dose systemic methotrexate-associated acute neurologic dysfunction.

Authors:  R J Packer; R I Grossman; J B Belasco
Journal:  Med Pediatr Oncol       Date:  1983
View more
  20 in total

1.  Reversible cytotoxic brain edema and facial weakness in uremic encephalopathy.

Authors:  Harald Prüss; Eberhard Siebert; Florian Masuhr
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

Review 2.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 3.  "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.

Authors:  K M O'Connor; G Barest; T Moritani; O Sakai; A Mian
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

4.  Methotrexate leukoencephalopathy mimics acute progressive stroke.

Authors:  Ryota Tanaka; Kumi Sasaki-Ikesawa; Hideki Shimura; Kenya Nishioka; Nobutaka Hattori; Shigeki Tanaka
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

Review 5.  Diffusion weighted magnetic resonance imaging and its recent trend-a survey.

Authors:  Geetha Soujanya Chilla; Cher Heng Tan; Chenjie Xu; Chueh Loo Poh
Journal:  Quant Imaging Med Surg       Date:  2015-06

6.  Hyperperfusion on magnetic resonance imaging in acute chemotherapy-related leukoencephalopathy.

Authors:  Lisa Michael El-Hakam; Melissa Beth Ramocki; James John Riviello; Anna Illner
Journal:  J Child Neurol       Date:  2010-04-02       Impact factor: 1.987

Review 7.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

8.  Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.

Authors:  Ajaya R Pande; Kumiko Ando; Reiichi Ishikura; Yuki Nagami; Masayo Ogawa; Norihiko Kamikonya; Yumi Kaneda; Takakuni Tanizawa; Norio Nakao
Journal:  Radiat Med       Date:  2006-08

9.  Children with epilepsy demonstrate macro- and microstructural changes in the thalamus, putamen, and amygdala.

Authors:  Sarah J MacEachern; Jonathan D Santoro; Kara J Hahn; Zachary A Medress; Ximena Stecher; Matthew D Li; Jin S Hahn; Kristen W Yeom; Nils D Forkert
Journal:  Neuroradiology       Date:  2019-12-18       Impact factor: 2.804

Review 10.  Diffusion-weighted MRI in neuro-oncology.

Authors:  Joachim M Baehring; Robert K Fulbright
Journal:  CNS Oncol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.